PNC Financial Services Group’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.6K | Sell |
445
-8
| -2% | -$407 | ﹤0.01% | 3513 |
|
|
2025
Q1 | $20.4K | Buy |
453
+282
| +165% | +$12.7K | ﹤0.01% | 3529 |
|
|
2024
Q4 | $7.07K | Sell |
171
-52
| -23% | -$2.15K | ﹤0.01% | 3923 |
|
|
2024
Q3 | $8.7K | Buy |
223
+132
| +145% | +$5.15K | ﹤0.01% | 3850 |
|
|
2024
Q2 | $3.11K | Sell |
91
-46
| -34% | -$1.57K | ﹤0.01% | 4129 |
|
|
2024
Q1 | $3.44K | Buy |
137
+96
| +234% | +$2.41K | ﹤0.01% | 4062 |
|
|
2023
Q4 | $1.21K | Buy |
41
+26
| +173% | +$768 | ﹤0.01% | 4285 |
|
|
2023
Q3 | $474 | Hold |
15
| – | – | ﹤0.01% | 4468 |
|
|
2023
Q2 | $388 | Buy |
+15
| New | +$388 | ﹤0.01% | 4612 |
|
|
2023
Q1 | – | Sell |
-18
| Closed | -$351 | – | 4771 |
|
|
2022
Q4 | $351 | Hold |
18
| – | – | ﹤0.01% | 4575 |
|
|
2022
Q3 | $0 | Hold |
18
| – | – | ﹤0.01% | 4548 |
|
|
2022
Q2 | $0 | Buy |
+18
| New | – | ﹤0.01% | 4629 |
|